Top

Published in:

01-03-2024 | Systemic Lupus Erythematosus | Clinical study

Hydroxychloroquine in SLE/RA pregnancy: no significantly increased risk of major congenital malformations

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Hydroxychloroquine exposure during early pregnancy among women with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) is not associated with a significantly increased risk of major congenital malformations (MCMs). …

Nguyen, NV, et al. Hydroxychloroquine in lupus or rheumatoid arthritis pregnancy and risk of major congenital malformations: a population-based cohort study. Rheumatology : 13 Mar 2024. Available from: URL: https://doi.org/10.1093/rheumatology/keae168

Title: Hydroxychloroquine in SLE/RA pregnancy: no significantly increased risk of major congenital malformations
Publication date: 01-03-2024
Publisher: Springer International Publishing
Keywords: Systemic Lupus Erythematosus
Rheumatoid Arthritis
Hydroxychloroquine
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-55050-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Hydroxychloroquine in SLE/RA pregnancy: no significantly increased risk of major congenital malformations

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Amoxicillin/clarithromycin

Antibacterial-related risk of new-onset IBD

Inotuzumab-ozogamicin/rituximab

Aspirin

Amoxicillin/Clindamycin/Cotrimoxazole

Glucocorticoids/methylprednisolone/tocilizumab